作者: Andrew P. Fuller , Darryl Palmer-Toy , Mark G. Erlander , Dennis C. Sgroi
DOI: 10.1023/B:JOMG.0000010033.49464.0C
关键词:
摘要: Advances in comprehensive genomic and proteomic technologies are providing researchers with an unprecedented opportunity for high-throughput molecular analysis of human breast cancer. Adaptation these to laser capture microdissection (LCM) is poised exert dramatic change on the pace cancer research. Although technical limitations have impeded coupling LCM, recent advances allowed successful application this cellular-based approach cancer, results such studies provided unique insight into disease. This holds great potential rapid advancement our understanding it hoped that advancements will lead novel predictive therapeutic strategies women review outlines current status adaptation advanced LCM highlights which has been applied